To investigate the putative modifying effect of dual antiplatelet therapy ( DAPT ) use on the incidence of stent thrombosis at 3 years in patients randomized to Endeavor zotarolimus-eluting stent ( E-ZES ) or Cypher sirolimus-eluting stent ( C-SES ) .